25 related articles for article (PubMed ID: 28373116)
1. Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic Approach.
Antognini N; Portman R; Dong V; Webb NJ; Chand DH
Ther Innov Regul Sci; 2024 Mar; 58(2):286-302. PubMed ID: 38110788
[TBL] [Abstract][Full Text] [Related]
2. Anti-Tn Monoclonal Antibody Ameliorates Hyperoxia-Induced Kidney Injury by Suppressing Oxidative Stress and Inflammation in Neonatal Mice.
Chow JC; Chou HC; Hwang J; Chen CM
Mediators Inflamm; 2021; 2021():1180543. PubMed ID: 34720748
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan Attenuates Gentamicin-induced Nephrotoxicity in Rats through Modulation of Oxidative Stress and Endogenous Antioxidant Capacity.
Al-Kuraishy HM; Al-Gareeb AI; Al-Nami MS
Int J Prev Med; 2020; 11():16. PubMed ID: 32175056
[TBL] [Abstract][Full Text] [Related]
4. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.
Lee M; Oh S; Lee HJ; Yeum TS; Lee JH; Yu SJ; Kim HY; Yoon JH; Lee HS; Kim YJ
J Viral Hepat; 2014 Dec; 21(12):873-81. PubMed ID: 24351112
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice.
Lin MT; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
PLoS One; 2016; 11(11):e0165416. PubMed ID: 27806120
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
Law ST; Lee MK; Li KK; Mok CK
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):193-8. PubMed ID: 26587867
[TBL] [Abstract][Full Text] [Related]
7. Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.
Law ST; Lee MK; Lee AS; Tung Y; Li KK
J Dig Dis; 2016 May; 17(5):325-33. PubMed ID: 27085094
[TBL] [Abstract][Full Text] [Related]
8. Telbivudine attenuates gentamicin-induced kidney injury in rats.
Kader C; Sunbul M; Das YK; Yarim M; Bedir A; Karaca E; Celikbilek M; Ozaras R
Int J Antimicrob Agents; 2017 May; 49(5):595-602. PubMed ID: 28373116
[TBL] [Abstract][Full Text] [Related]
9. Lamivudine versus telbivudine in the treatment of chronic hepatitis B: a systematic review and meta-analysis.
Jiang H; Wang J; Zhao W
Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):11-8. PubMed ID: 22898727
[TBL] [Abstract][Full Text] [Related]
10. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis.
Wu X; Cai S; Li Z; Zheng C; Xue X; Zeng J; Peng J
Virol J; 2016 Apr; 13():64. PubMed ID: 27062520
[TBL] [Abstract][Full Text] [Related]
11. Telbivudine for the management of chronic hepatitis B virus infection.
Matthews SJ
Clin Ther; 2007 Dec; 29(12):2635-53. PubMed ID: 18201580
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
